Trifluoroacetic acid → HCID 136232556, compound
Reaction equation
C(O)(C(F)(F)F)=O.[F:8][C:9]1([F:45])[CH2:11][CH:10]1[C:12]([NH:14][C:15]1[CH:23]=[C:22]2[C:18]([C:19]([C:30]3[NH:34][C:33]4[CH:35]=[CH:36][C:37]([N:39]5[CH2:44][CH2:43][O:42][CH2:41][CH2:40]5)=[CH:38][C:32]=4[N:31]=3)=[N:20][N:21]2C2CCCCO2)=[CH:17][CH:16]=1)=[O:13]>C(Cl)Cl>[F:45][C:9]1([F:8])[CH2:11][CH:10]1[C:12]([NH:14][C:15]1[CH:23]=[C:22]2[C:18]([C:19]([C:30]3[NH:31][C:32]4[CH:38]=[C:37]([N:39]5[CH2:44][CH2:43][O:42][CH2:41][CH2:40]5)[CH:36]=[CH:35][C:33]=4[N:34]=3)=[N:20][NH:21]2)=[CH:17][CH:16]=1)=[O:13]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
TFA (546 mg, 4.78 mmol) was added to solution of 2,2-difluoro-N-(3-(5-morpholino-1H-benzo[d]imidazol-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl)cyclopropan-ecarboxamide (25 mg, 0.048 mmol) in CH2Cl2 (5 mL). The reaction mixture was stirred overnight at room temperature, and then the solvent was removed in vacuo. Purification by flash chromatography (5% CH3OH/CH2Cl2) afforded the title compound (11 mg) as a solid. 1H NMR: (400 MHz, CD3OD): δ 8.28 (d, 1H, J=1.2 Hz), 8.19 (d, 1H, J=8.8 Hz), 7.61 (d, 1H, J=9.2 Hz), 7.33 (dd, 1H, J=1.6 and 8.8 Hz), 7.25 (dd, 1H, J=2.0 and 8.8 Hz), 7.13 (s, 1H), 3.86 (m, 4H), 3.21 (m, 4H), 2.78-2.70 (m, 1H), 2.14 (m, 1H), 1.90-1.84 (m, 1H); ESI-MS [M+H]+: 439.1.
Workup
- customthe solvent was removed in vacuo
- customPurification by flash chromatography (5% CH3OH/CH2Cl2)
Sources & evidence
- ORD record
- ord-06852dc2aacd4542978b106058b0f394
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08569511B2
Reaction notes
Loading…